Clinical Trial: Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional



Official Title: Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System): Marker of Venous Thrombosis Risk in Systemic Lupus and Antiphospholipid Syndrom

Brief Summary:

The purpose is to determine the hypercoagulable phenotype by thrombinography associated to an increased risk of symptomatic and objectively confirmed first venous thrombotic event. This is a case-control study in a population with patients having systemic lupus erythematosus (SLE) and/or antiphospholipid antibodies (APL).

Secondary purposes are:

  1. To determine the frequency of hypercoagulable phenotype in study population;
  2. To analyze the sensibility: consequences of variation of hypercoagulable phenotype threshold on the importance of risk;
  3. To identify (genetic and not) factors for hypercoagulable phenotype and their frequency in different groups.